Firy Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Firy Inc. trades at $10.21 (market cap $159.51M), while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.55B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 116.3× Firy Inc.'s market cap, and Zimmer Biomet Holdings Inc pays a 0.99% dividend while Firy Inc. pays none. Which is the better fit depends on your goals.
| FIRY | ZBH | |
|---|---|---|
Market Cap | $159.51M | $18.55B |
Sector | Consumer Cyclical | Health |
52-Week High | $12.45 | $107.71 |
52-Week Low | $2.28 | $79.58 |
Enterprise Value | $103.18M | $25.61B |
Dividend Yield | — | 0.99% |
Signals from Pluang's Aura AI — not financial advice
FIRY trades at $10.48, up 0.29% today, with a bullish technical outlook from moving averages. The company shows improving revenue trends ($104.5M in 2025) but continues to report significant losses (-$70.41M net income). Recent developments include a $719 million legal victory and corporate rebranding from Skillz Inc. Analyst sentiment remains mixed with a 60% hold rating.
The stock presents speculative potential from legal wins and revenue stabilization, but persistent negative margins and cash burn (-$86.41M net cash flow) pose substantial risks. Upside depends on achieving profitability, while downside risk remains elevated from ongoing operational losses.
No Aura AI signal available yet.
Trailing returns across standard periods
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →